MWM
HALO icon

Moran Wealth Management’s Halozyme HALO Stock Holding History

Moran Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Buy
80,381
+49,904
+164% +$3.4M 0.17% 183
2026
Q1 		$1.97M Sell
30,477
-5,119
-14% -$361K 0.06% 312
2025
Q4 		$2.4M Buy
35,596
+151
+0.4% +$10.2K 0.07% 268
2025
Q3 		$2.6M Buy
35,445
+25,652
+262% +$1.7M 0.08% 257
2025
Q2 		$509K Buy
+9,793
New +$557K 0.02% 414

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Moran Wealth Management's HALO Position: Q2 2026 in Review

Moran Wealth Management increased its Halozyme (HALO) stake by 164% in Q2 2026, buying an estimated $3.4M and bringing the position to 80,381 shares worth $6.29M. The position accounts for 0.17% of the portfolio, ranked #183.

Moran Wealth Management first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Moran Wealth Management held 80,381 shares of Halozyme worth $6.29M as of Q2 2026.
  • Moran Wealth Management bought 49,904 Halozyme shares in Q2 2026, an estimated $3.4M.
  • Halozyme made up 0.17% of Moran Wealth Management's portfolio in Q2 2026, its #183 holding.
  • Moran Wealth Management first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.